1.7 million, the project will run until the end of 2025 and will involve leading international institutions in the sector. The FAITHFUL, innovation project consortium, led by the Spanish startup Idoven, thanks to the support of EIT Health, has just launched the development of a technological solution that aims to prevent 4 out of 10 […]
IDIVAL researcher Javier Crespo is coordinating the congress, which will take place on 11th and 12th April The 1st International Symposium on Rare Liver Diseases 2024 will bring together leading national and international experts in the field of rare liver diseases, with the aim of sharing knowledge, scientific advances and clinical experiences relevant to the […]
The work focuses on the transport of drugs through lipid nanosystems. The University of Cantabria has announced the winners of the ‘Juan María Parés Research Awards’ in the doctoral thesis category, highlighting the work of Lourdes Valdivia Fernández in the area of Health Sciences. Valdivia’s thesis was supervised by researchers Mónica López Fanarraga and Rafael […]
The work will allow the development of an optical sensor for the precise identification of tumour margins. Researchers from the Cell Signalling and Therapeutic Targets in Cancer Group of the Valdecilla Research Institute (IDIVAL) and the Optics Group of the University of Cantabria (UC) are collaborating in the development of an optical sensor to aid […]
The scientist considers that “this recognition should serve as an incentive to promote, even more, the interest in research among the professionals of the Marqués de Valdecilla University Hospital”. Julio Pascual Gómez, head of the ‘Clinical and Genetics of Headaches’ group at the Valdecilla Research Institute (IDIVAL) and head of the Neurology Service at the […]
The initiative is formed by a consortium between IDIVAL, the Ámbar Group and the University of Cantabria The scientific director of the Marqués de Valdecilla Health Research Institute (IDIVAL), Marcos López-Hoyos; the rector of the University of Cantabria (UC), Ángel Pazos; and the president of Grupo Ámbar, Pablo Gómez, presented yesterday, together with the researcher […]
Previous hypertension, diabetes and renal insufficiency could alter plasma markers A multidisciplinary research team belonging to the Neurodegenerative Diseases Group of IDIVAL and the Cognitive Impairment Unit of the Neurology Service of the Marqués de Valdecilla University Hospital (HUMV) has conducted a study aimed at understanding how different physiological variables and previous diseases could influence […]
portal point to a high visibility of IDIVAL authors with more than 62,000 citations of articles published in the period 2018-2022. In this way, the Valdecilla brand exceeds 280,000 citations since its creation. Of note in the period 2018-22 are the citations of papers published in the areas of Immunology (1,383 citations), Pharmacology (1,307 citations) […]
It will allow Cantabria to implement pilot initiatives to promote healthier environments and reduce social inequalities The EU recently approved a proposal for a Joint Action for the prevention of Cancer and other Non Communicable Diseases (NCDs) with an amount of 75 million euros, which makes it a landmark initiative in public health. A […]
The results of the largest European prospective multicenter study on the surgical treatment of right colon cancer have been published. The MIRCAST study, an International multicenter project led for the whole of Europe from the IDIVAL Institute, was born in 2018 with the aim of evaluating the different ways of performing intestinal anastomosis after […]
